The Effects of Chlorhexidine/Thymol Varnish on Partial Denture Patient

May 12, 2017 updated by: Rosa Moreno Lopez

The Effects of Chlorhexidine/Thymol Varnish on the Abutment Teeth in Partial Denture Wearers.

Cervitec, a chlorhexidine based varnished has been proven to reduce caries risk in younger populations. This study wants to investigate if the use of this product would reduce the risk of losing abutment teeth on patients that are wearing partial dentures as the literature has proven that these teeth are more prone to caries and periodontal disease.

The primary objectives of this research project are to:

  1. Assess if the topical application of CHX/thymol varnish every three months on partial denture abutment teeth results in a clinicallu significant decrease in any loss of attachment compared to no application, and
  2. Assess if the topical application of CHX/thymol vanirhs every three months on partial denture abutment teeth results in a clinically significant decrease in carious lesion development or progression compared to no application.

The secondary objectives of this research project are to:

1. Assess of the topical application of CHX/thymol varnish every three months on partial denture abutment teeth compared to no application results in a clinically significant difference in:

  1. Bleeding on probing (BoP).
  2. Plaque formation.
  3. Periodontal pocket depths.
  4. Microbial composition and GCF cytokine profile of the sub gingival environment.
  5. The patients self perception of oral health.

Study Overview

Status

Withdrawn

Intervention / Treatment

Detailed Description

  • 2 baseline samples of the Gingival Crevicular Fluid (GCF) and the subgingival samples. The first baseline sample will be done on the day of the first impressions and the second one the day of denture fitting.
  • The following information will be recorded on the CRFs: Silness and Löe Plaque index, BoP, probing depth, clinical attachment level, LoA, Kennedy classification, material of the partial denture and type of clasp (or no clasp) and ICDAS code.
  • The patient will also fill in the OHIP-14 questionnaire (Oral Health Impact Profile) to assess their self perception of oral health.
  • A photograph of the abutment teeth and the partial denture will be taken.
  • We will also take a full history of the patient including: name, DOB and medications.
  • The GCF and subgingival sampled will be taken every 6 months on the appointment where the varnish is applied.
  • All the laboratory samples will be labelles with the same identification number that the patient has been allocated and a date will also be written on it. All the samples will be analysed in Plymouth and stored in a - 50°C freezer (the samples taken at the University of Aberdeen will be stored in the same type of freezer and shipped periodically to the Penninsula University for tests maintaining the same temperature conditions). They will be testing the microbial composition and GCF cytokine profile of the sub gingival environment
  • All measurements will be reassessed at 12 months and 24 months. In addition to the denture hygiene index: Budtz-Jørgensen (1977) Index (plaque accumulation on the denture).

The data will be collected by one clinician in each dental school. All clinicians will be calibrated appropriately.

Calibration: Before any examination starts we will assess the consistency of each examiner (intra-exmainer) and also the variation between exmainers (inter-exmainer reproducibility). Each examiner will independently examiner the same group of 20 subjects and compare his or her findings. When findings contain major discrepancies, subjects should be recalled in order that differences in diagnoses can be reviewed by the exmainers and resolved by group discussion. If certain examiners consistently produce significantly different results from the majority, and attmepts to correct their performance fail, they will be excluded from the team. It will be made clear to all potential examiners, before these exmainations begin, that ability to standardize examination results is not a measure of clinical skills (Oral Health Surveys 4th edition. WHO. Geneva 1997) All the data will be recorded on the case report forms (CRFs).

Study Type

Interventional

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Aberdeenshire
      • Aberdeen, Aberdeenshire, United Kingdom, AB252ZR
        • University of Aberdeen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients that are going to have a new denture fitted at the Dental School of the University of Aberdeen and Penninsula Dental School.
  • Patients aged 18 years or over.

Exclusion Criteria:

  • Patients that already have a denture.
  • Patients that are taking antibiotics.
  • Patients allergic to any of the components of the products.
  • Pregnant women.
  • Severe systemic illness.
  • Patient with active periodontal disease (BoP and pockets ≥3mm) on abutment teeth.
  • Presence of caries on abutment teeth.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Chlorhexidine/Thymol varnish
Participants to the study will receive an application of either the placebo or the product being studied every 3 months. This will be applied on all abutment teeth using a microbrush by "painting" it over the surfaces of these teeth.
This will be applied on abutment teeth on partial denture wearers every 3 months during a period of 2 years.
Other Names:
  • Cervitec Plus (1% chlorhexidine plus 1% thymol)
Placebo Comparator: Placebo varnish
Participants to the study will receive an application of either the placebo or the product being studied every 3 months. This will be applied on all abutment teeth using a microbrush and "painting" it on all the surfaces of these teeth..
This will be applied on abutment teeth on partial denture wearers every 3 months during a period of 2 years.
Other Names:
  • Cervitec Plus (1% chlorhexidine plus 1% thymol)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess if the topical application of CHX/thymol varnish every three months on partial denture abutment teeth results in a clinicallu significant decrease in any loss of attachment compared to no application
Time Frame: Assesed at the begining, at 12 months and at 24 months
we will measure the Loss of Attachment (LoA) around each abutment tooth at 6 points
Assesed at the begining, at 12 months and at 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess if the topical application of CHX/thymol vanirhs every three months on partial denture abutment teeth results in a clinically significant decrease in carious lesion development or progression compared to no application
Time Frame: at the beginning, at 12 months and at 24 months
We will record the presence of dental caries using ICDAS
at the beginning, at 12 months and at 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Rosa Moreno Lopez, BDS, University of Aberdeen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 10, 2017

Primary Completion (Anticipated)

September 10, 2019

Study Completion (Anticipated)

December 10, 2020

Study Registration Dates

First Submitted

July 24, 2014

First Submitted That Met QC Criteria

July 27, 2014

First Posted (Estimate)

July 29, 2014

Study Record Updates

Last Update Posted (Actual)

May 15, 2017

Last Update Submitted That Met QC Criteria

May 12, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

within 6 months

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caries

Clinical Trials on Chlorhexidine/Thymol varnish

3
Subscribe